Let’s start up with the current stock price of BELLUS Health Inc. (BLU), which is $7.81 to be very precise. The Stock rose vividly during the last session to $7.84 after opening rate of $6.78 while the lowest price it went was recorded $6.70 before closing at $6.78.Recently in News on May 11, 2022, BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights. – End-of-Phase 2 meeting with the U.S. Food and Drug Administration (“FDA”) scheduled for June of 2022; Plan to initiate the Phase 3 program in the second half of 2022 -. You can read further details here
BELLUS Health Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $9.09 on 05/03/22, with the lowest value was $4.98 for the same time period, recorded on 01/24/22.
BELLUS Health Inc. (BLU) full year performance was 126.38%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, BELLUS Health Inc. shares are logging -20.63% during the 52-week period from high price, and 200.38% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.60 and $9.84.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 941326 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the BELLUS Health Inc. (BLU) recorded performance in the market was -2.98%, having the revenues showcasing 7.13% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 906.43M, as it employees total of 40 workers.
Market experts do have their say about BELLUS Health Inc. (BLU)
During the last month, 0 analysts gave the BELLUS Health Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.04, with a change in the price was noted -0.12. In a similar fashion, BELLUS Health Inc. posted a movement of -1.51% for the period of last 100 days, recording 985,028 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BLU is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of BELLUS Health Inc. (BLU)
Raw Stochastic average of BELLUS Health Inc. in the period of last 50 days is set at 64.84%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 53.28%. In the last 20 days, the company’s Stochastic %K was 27.14% and its Stochastic %D was recorded 15.80%.
Bearing in mind the latest performance of BELLUS Health Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -2.98%. Additionally, trading for the stock in the period of the last six months notably improved by 9.54%, alongside a boost of 126.38% for the period of the last 12 months. The shares increased approximately by -6.35% in the 7-day charts and went down by -3.94% in the period of the last 30 days. Common stock shares were driven by 7.13% during last recorded quarter.